Morgan Stanley downgraded shares of Fresenius Medical Care (NYSE:FMS) from an overweight rating to an equal weight rating in a research report sent to investors on Monday morning, MarketBeat reports.

Other analysts also recently issued reports about the stock. Royal Bank of Canada reiterated a hold rating and issued a $44.00 price target on shares of Fresenius Medical Care in a research report on Wednesday, September 13th. Zacks Investment Research downgraded shares of Fresenius Medical Care from a strong-buy rating to a hold rating in a research report on Wednesday, August 16th. Finally, DZ Bank reiterated a buy rating on shares of Fresenius Medical Care in a research report on Monday, November 13th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $48.50.

Fresenius Medical Care (NYSE FMS) opened at $51.52 on Monday. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55. Fresenius Medical Care has a 52-week low of $39.46 and a 52-week high of $52.38. The stock has a market cap of $32,140.69, a PE ratio of 23.41, a price-to-earnings-growth ratio of 2.35 and a beta of 0.45.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its stake in Fresenius Medical Care by 13.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 92,150 shares of the company’s stock worth $3,882,000 after purchasing an additional 11,257 shares in the last quarter. SG Americas Securities LLC increased its stake in Fresenius Medical Care by 205.4% during the 2nd quarter. SG Americas Securities LLC now owns 31,039 shares of the company’s stock worth $1,500,000 after purchasing an additional 20,875 shares in the last quarter. BB&T Securities LLC increased its stake in Fresenius Medical Care by 1.4% during the 2nd quarter. BB&T Securities LLC now owns 15,053 shares of the company’s stock worth $727,000 after purchasing an additional 211 shares in the last quarter. Intrust Bank NA increased its stake in Fresenius Medical Care by 21.1% during the 3rd quarter. Intrust Bank NA now owns 16,865 shares of the company’s stock worth $825,000 after purchasing an additional 2,934 shares in the last quarter. Finally, Roundview Capital LLC bought a new stake in Fresenius Medical Care during the 2nd quarter worth approximately $391,000. 3.03% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/15/fresenius-medical-care-fms-lowered-to-equal-weight-at-morgan-stanley.html.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care (NYSE:FMS)

Receive News & Stock Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related stocks with our FREE daily email newsletter.